Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?

Gastric cancer is one of the five most common types of cancer worldwide. Due to the heterogeneous course and the involvement of many risk factors, its treatment and diagnosis is an important challenge for modern medicine. Recent studies have emphasized the i role of Toll-like receptors (TLRs) expres...

Full description

Bibliographic Details
Main Authors: Marek Majewski, Kamil Torres, Paulina Mertowska, Sebastian Mertowski, Izabela Korona-Głowniak, Jan Korulczyk, Witold Zgodziński, Ewelina Grywalska
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/6/5824
_version_ 1797611151697117184
author Marek Majewski
Kamil Torres
Paulina Mertowska
Sebastian Mertowski
Izabela Korona-Głowniak
Jan Korulczyk
Witold Zgodziński
Ewelina Grywalska
author_facet Marek Majewski
Kamil Torres
Paulina Mertowska
Sebastian Mertowski
Izabela Korona-Głowniak
Jan Korulczyk
Witold Zgodziński
Ewelina Grywalska
author_sort Marek Majewski
collection DOAJ
description Gastric cancer is one of the five most common types of cancer worldwide. Due to the heterogeneous course and the involvement of many risk factors, its treatment and diagnosis is an important challenge for modern medicine. Recent studies have emphasized the i role of Toll-like receptors (TLRs) expressed on selected cells of the immune system in the pathogenesis of gastric cancer. The aim of this study was to determine the prevalence of TLR2 on T lymphocytes, B lymphocytes, monocytes, and dendritic cells in patients diagnosed with gastric cancer, with particular emphasis on the stage of the disease. Based on the obtained results, we have shown that patients with gastric cancer are characterized by a higher percentage of all tested populations of peripheral blood immune cells expressing TLR2 in relation to patients from the control group. Moreover, a detailed analysis of the collected results showed a significant link between TLR2 and the stage of the disease.
first_indexed 2024-03-11T06:24:45Z
format Article
id doaj.art-1d756d37211e4538bf515feb800c0337
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T06:24:45Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1d756d37211e4538bf515feb800c03372023-11-17T11:39:35ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01246582410.3390/ijms24065824Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?Marek Majewski0Kamil Torres1Paulina Mertowska2Sebastian Mertowski3Izabela Korona-Głowniak4Jan Korulczyk5Witold Zgodziński6Ewelina Grywalska72nd Department of General, Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract, Medical University of Lublin, 20-081 Lublin, PolandChair and Department of Didactics and Medical Simulation, Medical University of Lublin, 20-093 Lublin, PolandDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, PolandDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, PolandDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, PolandChair and Department of Didactics and Medical Simulation, Medical University of Lublin, 20-093 Lublin, Poland1st Department of General and Transplant Surgery and Clinical Nutrition, Medical University of Lublin, 20-090 Lublin, PolandDepartment of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, PolandGastric cancer is one of the five most common types of cancer worldwide. Due to the heterogeneous course and the involvement of many risk factors, its treatment and diagnosis is an important challenge for modern medicine. Recent studies have emphasized the i role of Toll-like receptors (TLRs) expressed on selected cells of the immune system in the pathogenesis of gastric cancer. The aim of this study was to determine the prevalence of TLR2 on T lymphocytes, B lymphocytes, monocytes, and dendritic cells in patients diagnosed with gastric cancer, with particular emphasis on the stage of the disease. Based on the obtained results, we have shown that patients with gastric cancer are characterized by a higher percentage of all tested populations of peripheral blood immune cells expressing TLR2 in relation to patients from the control group. Moreover, a detailed analysis of the collected results showed a significant link between TLR2 and the stage of the disease.https://www.mdpi.com/1422-0067/24/6/5824Toll-like receptorTLR2gastric cancerimmune system
spellingShingle Marek Majewski
Kamil Torres
Paulina Mertowska
Sebastian Mertowski
Izabela Korona-Głowniak
Jan Korulczyk
Witold Zgodziński
Ewelina Grywalska
Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
International Journal of Molecular Sciences
Toll-like receptor
TLR2
gastric cancer
immune system
title Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
title_full Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
title_fullStr Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
title_full_unstemmed Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
title_short Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?
title_sort could toll like receptor 2 serve as biomarker to detect advanced gastric cancer
topic Toll-like receptor
TLR2
gastric cancer
immune system
url https://www.mdpi.com/1422-0067/24/6/5824
work_keys_str_mv AT marekmajewski couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT kamiltorres couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT paulinamertowska couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT sebastianmertowski couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT izabelakoronagłowniak couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT jankorulczyk couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT witoldzgodzinski couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer
AT ewelinagrywalska couldtolllikereceptor2serveasbiomarkertodetectadvancedgastriccancer